Literature DB >> 18798835

A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection.

Mercedes Ficarra1, Joyce S A Ibana, Constance Poretta, Liang Ma, Leann Myers, Stephanie N Taylor, Sheila Greene, Barbara Smith, Michael Hagensee, David H Martin, Alison J Quayle.   

Abstract

PROBLEM: The endocervix is a major target of Chlamydia trachomatis infection, but little is known about the immune repertoire in this tissue, or its response to these common bacteria. METHOD OF STUDY: Using a cytobrush, we isolated cells from the endocervix of 20 women during C. trachomatis infection, and post-antibiotic treatment. Endocervical swabs and blood were taken in parallel. Endocervical cells were enumerated, and endocervical and blood T cells immunophenotyped. Chlamydia trachomatis was genotyped by sequence analysis of the OmpA gene, and quantified by culture.
RESULTS: Chlamydia trachomatis genotypes were D, E, F and Ia, and infectious burden varied considerably. Endocervical T cell and neutrophil numbers were highly elevated during infection, with both CD4 and CD8 T-cell subsets accumulating. Regardless of the presence or absence of infection, the endocervical cell infiltrate was dominated by effector memory T cells, and the numbers of CCR5 and CD103 expressing T cells was significantly higher than in the blood. Human leukocyte antigen (HLA-DR) expression by endocervical T cells was significantly increased during infection.
CONCLUSION: The human endocervix exhibits a distinct cellular response to C. trachomatis infection that can be longitudinally evaluated by cytobrush sampling. Infecting organisms can be sampled and analyzed in parallel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798835      PMCID: PMC2574558          DOI: 10.1111/j.1600-0897.2008.00639.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  37 in total

1.  Characterization of lymphocyte response in the female genital tract during ascending Chlamydial genital infection in the guinea pig model.

Authors:  R G Rank; A K Bowlin; K A Kelly
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes.

Authors:  Eric J Kunkel; Judie Boisvert; Kristine Murphy; Mark A Vierra; Mark C Genovese; Andrew J Wardlaw; Harry B Greenberg; Martin R Hodge; Lijun Wu; Eugene C Butcher; James J Campbell
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 3.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo.

Authors:  R A Hawkins; R G Rank; K A Kelly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Duration of untreated genital infections with chlamydia trachomatis: a review of the literature.

Authors:  M R Golden; J A Schillinger; L Markowitz; M E St Louis
Journal:  Sex Transm Dis       Date:  2000-07       Impact factor: 2.830

Review 6.  Transforming growth factor beta--a mediator of immune deviation in seminal plasma.

Authors:  Sarah A Robertson; Wendy V Ingman; Sean O'Leary; David J Sharkey; Kelton P Tremellen
Journal:  J Reprod Immunol       Date:  2002 Oct-Nov       Impact factor: 4.054

7.  Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.

Authors:  Barbara L Shacklett; Catherine A Cox; Johan K Sandberg; Neil H Stollman; Mark A Jacobson; Douglas F Nixon
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Implications of blood contamination for assessment of local cellular immunity in the endocervix.

Authors:  Alison J Quayle; Meha Shah; Susan Cu-Uvin; Joseph A Politch; Cinnie Chou; Deborah J Anderson; Ruth Tuomala; Peggy A Crowley-Nowick; Ann Duerr
Journal:  AIDS Res Hum Retroviruses       Date:  2004-05       Impact factor: 2.205

9.  Characterization of variants of the gene encoding the p55 antigen in Pneumocystis from rats and mice.

Authors:  Liang Ma; Geetha Kutty; Qiuyao Jia; Joseph A Kovacs
Journal:  J Med Microbiol       Date:  2003-11       Impact factor: 2.472

10.  Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture.

Authors:  Bruce K Patterson; Alan Landay; Joan N Siegel; Zareefa Flener; Dennis Pessis; Antonio Chaviano; Robert C Bailey
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

View more
  27 in total

1.  Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.

Authors:  Rhoda Sperling; Thomas A Kraus; Jian Ding; Alina Veretennikova; Elizabeth Lorde-Rollins; Tricia Singh; Yungtai Lo; Alison J Quayle; Theresa L Chang
Journal:  J Reprod Immunol       Date:  2013-08-08       Impact factor: 4.054

2.  Chlamydia trachomatis persistence in vitro: an overview.

Authors:  Priscilla B Wyrick
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

3.  Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.

Authors:  Tara R Henning; Katherine Butler; Debra Hanson; Gail Sturdevant; Shanon Ellis; Elizabeth M Sweeney; James Mitchell; Frank Deyounks; Christi Phillips; Carol Farshy; Yetunde Fakile; John Papp; W Evan Secor; Harlan Caldwell; Dorothy Patton; Janet M McNicholl; Ellen Kersh
Journal:  J Infect Dis       Date:  2014-04-21       Impact factor: 5.226

Review 4.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 5.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

6.  Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation.

Authors:  Jian Ding; Aprille Rapista; Natalia Teleshova; Goar Mosoyan; Gary A Jarvis; Mary E Klotman; Theresa L Chang
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

7.  Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion.

Authors:  Chris L McGowin; Rochelle S Annan; Alison J Quayle; Sheila J Greene; Liang Ma; Miriam M Mancuso; David Adegboye; David H Martin
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

Review 8.  Does HIV Exploit the Inflammatory Milieu of the Male Genital Tract for Successful Infection?

Authors:  Rachel T Esra; Abraham J Olivier; Jo-Ann S Passmore; Heather B Jaspan; Rushil Harryparsad; Clive M Gray
Journal:  Front Immunol       Date:  2016-06-24       Impact factor: 7.561

9.  Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis.

Authors:  Jessica Radzio; Tara Henning; Leecresia Jenkins; Shanon Ellis; Carol Farshy; Christi Phillips; Angela Holder; Susan Kuklenyik; Chuong Dinh; Debra Hanson; Janet McNicholl; Walid Heneine; John Papp; Ellen N Kersh; J Gerardo García-Lerma
Journal:  J Infect Dis       Date:  2016-01-06       Impact factor: 5.226

Review 10.  The structure of the human vaginal stratum corneum and its role in immune defense.

Authors:  Deborah J Anderson; Jai Marathe; Jeffrey Pudney
Journal:  Am J Reprod Immunol       Date:  2014-03-24       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.